Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-06 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.250 | -0.280 | -0.0300 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
CLBS | Caladrius Biosciences | 1.79 | -0.03 | -1.65% | 106.5M |
You can purchase shares of Caladrius Biosciences (NASDAQ: CLBS) through any online brokerage.
Other companies in Caladrius Biosciences’s space includes: AEterna Zentaris (NASDAQ:AEZS), Cleveland BioLabs (NASDAQ:CBLI) and Celyad Oncology (NASDAQ:CYAD).
The latest price target for Caladrius Biosciences (NASDAQ: CLBS) was reported by Brookline Capital on 2021-03-03. The analyst firm set a price target for 10.00 expecting CLBS to rise to within 12 months (a possible 458.66% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Caladrius Biosciences (NASDAQ: CLBS) is $1.79 last updated Fri Mar 05 2021 21:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Caladrius Biosciences.
There is no upcoming split for Caladrius Biosciences.